MedTrace Logo

CoViD-19 Patient in Reims University Hospital in March to April 2020

NCT04553575 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2022-08-08

No results posted yet for this study

Summary

Medical context: Follow-up of a retrospective cohort of 499 cases of CoViD-19, hospitalized at the University Hospital of Reims during the health crisis, prospectively up to two years of follow-up.

Possible intervention for serological monitoring, leading to a change from category 3 to category 2 (French law on human person research)

Aim of the study: To know the factors of gravity of CoViD-19, to know its prognostic factors, to see how the evolution of the treatments implemented have influenced the fate of the patients.

Material and methods:

Type of study: cohort study Population: Patients in the CoViD-19 cohort - Reims Calendar: September 2020 - July 2022

Expected results: Better knowledge of the cares of patients with CoViD-19

Conditions

  • Coronavirus Infections

Interventions

BIOLOGICAL

serology

biological blood samples withdrawn at 6, 12 and 24 months

Sponsors & Collaborators

  • CHU de Reims

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-25
Primary Completion
2022-05-24
Completion
2022-08-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04553575 on ClinicalTrials.gov